[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Imelda GI Clinical Research Center\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":68},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,42],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100640283","leucine-rich-2-glycoprotein-correlation-with-clinical-endoscopic-and-histological-disease-activity-of-ibd-in-a-european-context-100640283",false,"NCT07621783","Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context","Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context: LEADER Trial.","LEADER","Inclusion Criteria:\n\n1. ≥18 years\n2. Patient with confirmed diagnosis of IBD\n3. Patient with planned endoscopy (ileocolonoscopy for Crohn's disease (CD)\u002Fulcerative colitis (UC) or sigmoidoscopy for UC) for the assessment of endoscopic disease activity according to routine practice\n4. willing to provide informed consent\n\nExclusion Criteria:\n\n1. Patient with IBD unspecified\n2. Patient with ileo- or colostomy\n3. Patient with total colectomy\n4. Women that are pregnant","ALL","16 Years",{"count":20,"type":21},100,"ESTIMATED","OBSERVATIONAL","Prospectively study the correlation between Leucine-rich α2-glycoprotein (LRG) and clinical\u002Fendoscopic\u002Fhistological disease activity in patients with inflammatory bowel disease (IBD) in Europe.",[25,26],"Crohn Disease (CD)","Ulcerative Colitis (UC)",[28],"Crohn; ulcerative colitis, LRG, endoscopic remission, endoscopic activity, PRO, quality of life","RECRUITING","2026-05-29",{"date":32,"type":33},"2026-06-02","ACTUAL",{"date":35,"type":33},"2026-05-01",{"date":37,"type":21},"2026-12-31",{"name":39,"class":40},"Imelda GI Clinical Research Center","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":17,"minAge":49,"maxAge":4,"enrollmentInfo":50,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":61,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":66,"leadSponsor":67,"locationsCount":41},"100605227","multiple-digital-biomarkers-for-optimization-of-ibd-care-100605227","NCT07159776","Multiple Digital Biomarkers for Optimization of IBD Care","LEGEND-IBD","Inclusion Criteria:\n\n* Males or females aged \\> 18 years\n* Diagnosis of CD, UC or IBD-unspecified for at least 1 month\n* Treatment with conventional or advanced therapy for IBD at initiation of the study\n* The patient must have access to an email address\n* The patient must be willing to perform all the groceries shopping at any of the Colruyt Group stores during this study, using an Xtra card created by the study team.\n* Capacity to independently answer regular digital questionnaires\n* Capacity and willingness to use a smartphone and activity tracker\n\nExclusion Criteria:\n\n* Planned extended (\\> 1 month) overseas travel during the study period of 12 months, if internet access would be impossible, inconvenient or unaffordable during this time\n* Previous colectomy\n* Inability to communicate well with investigators or unable to comply with the study requirements\n* Significant medical condition interfering with physiological measurements trough a wearable device (heart failure, pacemaker or defibrillator)\n* Inclusion or planned inclusion in an interventional IBD-related clinical trial","18 Years",{"count":51,"type":21},80,"To develop digital biomarkers associated with disease activity of inflammatory bowel disease",[25,26,54],"Inflammatory Bowel Disease (IBD)",[56,57,58,59,60],"biomarkers","artificial intelligence","wearable","shopping data","life style","NOT_YET_RECRUITING","2025-08-29",{"date":64,"type":33},"2025-09-08",{"date":64,"type":21},{"date":37,"type":21},{"name":39,"class":40},""]